UMIN-CTR Clinical Trial

Basic information
Public title	Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Acronym	Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Scientific Title	Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Scientific Title:Acronym	Competing interests among Authors of Clinical Practice Guidelines for Dermatology Update Guidelines produced between 2017 and 2019
Region	North America

Condition
Condition	This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published.
Classification by specialty	Dermatology
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published..
Basic objectives2	Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	This article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published.
Key secondary outcomes

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	18 years-old <=
Age-upper limit	99 years-old >=
Gender	Male and Female
Key inclusion criteria	Clinical Practice Guidelines for Dermatology published between 2017 and 2019
Key exclusion criteria	Clinical Practice Guidelines for Dermatology published between 2017 and 2019
Target sample size

Research contact person
Name of lead principal investigator	1st name Micah Middle name Last name Hartwell
Organization	Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Division name	CHS
Zip code	74107
Address	1111 West 17th Street
TEL	9185948426
Email	micah.hartwell@okstate.edu

Public contact
Name of contact person	1st name Matt Middle name Last name Vassar
Organization	Oklahoma State University
Division name	CHS
Zip code	74107
Address	1111 West 17th Street
TEL	9185948426
Homepage URL
Email	matt.vassar@okstate.edu

Sponsor
Institute	Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Institute
Department

Funding Source
Organization	Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	OSU
Address	111 W 174th st
Tel	9185948426
Email	matt.vassar@okstate.edu

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2020 Year 03 Month 03 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Preinitiation
Date of protocol fixation	2020 Year 03 Month 03 Day
Date of IRB
Anticipated trial start date	2020 Year 03 Month 04 Day
Last follow-up date	2021 Year 03 Month 03 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	his article examines FCOIs among authors of dermatological CPGs (new or updated) published from 2017-2019 to determine their continued presence after the original article was published

Management information
Registered date	2020 Year 03 Month 03 Day
Last modified on	2020 Year 03 Month 03 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045262